Baidu
map

传染科指南

订阅

MedSci主页 / 所有栏目 / 传染科指南

2021 法国指南建议：抗感染治疗时间

2021-03-15 国外感染病相关专家组（统称） Infect Dis Now.2021 Mar;51(2):114-139.

抗感染治疗

在全世界范围内，抗生素耐药性已经成为公共卫生关注的主要问题，在这种情况下缩短抗生素治疗的时间至关重要。本文主要针对抗生素抗感染治疗的疗程提供指导建议。

中文标题：

2021 法国指南建议：抗感染治疗时间

英文标题：

Anti-infectious treatment duration: The SPILF and GPIP French guidelines and recommendations

发布机构：

国外感染病相关专家组（统称）

发布日期：

2021-03-15

简要介绍：

在全世界范围内，抗生素耐药性已经成为公共卫生关注的主要问题，在这种情况下缩短抗生素治疗的时间至关重要。本文主要针对抗生素抗感染治疗的疗程提供指导建议。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 法国指南建议：抗感染治疗时间.pdf)] GetToolGuiderByIdResponse(projectId=1, id=d56941c00212a6d4, title=2021 法国指南建议：抗感染治疗时间, enTitle=Anti-infectious treatment duration: The SPILF and GPIP French guidelines and recommendations, guiderFrom=Infect Dis Now.2021 Mar;51(2):114-139., authorId=0, author=, summary=在全世界范围内，抗生素耐药性已经成为公共卫生关注的主要问题，在这种情况下缩短抗生素治疗的时间至关重要。本文主要针对抗生素抗感染治疗的疗程提供指导建议。, cover=https://img.medsci.cn/202171/1625069448174_2020535.jpg, journalId=0, articlesId=null, associationId=1273, associationName=国外感染病相关专家组（统称）, associationIntro=, copyright=0, guiderPublishedTime=Mon Mar 15 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>在全世界范围内，抗生素耐药性已经成为公共卫生关注的主要问题，在这种情况下缩短抗生素治疗的时间至关重要。本文主要针对抗生素抗感染治疗的疗程提供指导建议。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=15196, tagName=抗感染治疗)], categoryList=[CategoryDto(categoryId=9, categoryName=传染科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=15196, guiderKeyword=抗感染治疗, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4578, appHits=167, showAppHits=0, pcHits=427, showPcHits=4410, likes=1, shares=9, comments=11, approvalStatus=1, publishedTime=Wed Jun 30 23:53:27 CST 2021, publishedTimeString=2021-03-15, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=qiushida2, createdTime=Wed Jun 30 23:51:45 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 18:24:58 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 法国指南建议：抗感染治疗时间.pdf)])
2021 法国指南建议：抗感染治疗时间.pdf
下载请点击：
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1190734, encodeId=ea0d1190e344a, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f922820053, createdName=pp.dog.1001, createdTime=Mon Feb 07 14:42:47 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056126, encodeId=eec61056126ef, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24d05619594, createdName=ms3000000366766127, createdTime=Wed Sep 29 15:07:44 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056125, encodeId=f204105612542, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24d05619594, createdName=ms3000000366766127, createdTime=Wed Sep 29 15:07:10 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013550, encodeId=1a051013550cf, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee6d5591864, createdName=ms6000000226610455, createdTime=Wed Sep 01 20:49:40 CST 2021, time=2021-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009096, encodeId=511710090960c, content=点赞👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/88514d1d39d84f3ba85db20af43d358d/2ce7a3acea30442ab95b578d804b69bc.jpg, createdBy=a9525438381, createdName=于四方, createdTime=Wed Aug 18 14:54:54 CST 2021, time=2021-08-18, status=1, ipAttribution=)]
    2022-02-07 pp.dog.1001

    赞

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1190734, encodeId=ea0d1190e344a, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f922820053, createdName=pp.dog.1001, createdTime=Mon Feb 07 14:42:47 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056126, encodeId=eec61056126ef, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24d05619594, createdName=ms3000000366766127, createdTime=Wed Sep 29 15:07:44 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056125, encodeId=f204105612542, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24d05619594, createdName=ms3000000366766127, createdTime=Wed Sep 29 15:07:10 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013550, encodeId=1a051013550cf, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee6d5591864, createdName=ms6000000226610455, createdTime=Wed Sep 01 20:49:40 CST 2021, time=2021-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009096, encodeId=511710090960c, content=点赞👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/88514d1d39d84f3ba85db20af43d358d/2ce7a3acea30442ab95b578d804b69bc.jpg, createdBy=a9525438381, createdName=于四方, createdTime=Wed Aug 18 14:54:54 CST 2021, time=2021-08-18, status=1, ipAttribution=)]
    2021-09-29 ms3000000366766127

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1190734, encodeId=ea0d1190e344a, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f922820053, createdName=pp.dog.1001, createdTime=Mon Feb 07 14:42:47 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056126, encodeId=eec61056126ef, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24d05619594, createdName=ms3000000366766127, createdTime=Wed Sep 29 15:07:44 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056125, encodeId=f204105612542, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24d05619594, createdName=ms3000000366766127, createdTime=Wed Sep 29 15:07:10 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013550, encodeId=1a051013550cf, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee6d5591864, createdName=ms6000000226610455, createdTime=Wed Sep 01 20:49:40 CST 2021, time=2021-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009096, encodeId=511710090960c, content=点赞👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/88514d1d39d84f3ba85db20af43d358d/2ce7a3acea30442ab95b578d804b69bc.jpg, createdBy=a9525438381, createdName=于四方, createdTime=Wed Aug 18 14:54:54 CST 2021, time=2021-08-18, status=1, ipAttribution=)]
    2021-09-29 ms3000000366766127

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1190734, encodeId=ea0d1190e344a, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f922820053, createdName=pp.dog.1001, createdTime=Mon Feb 07 14:42:47 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056126, encodeId=eec61056126ef, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24d05619594, createdName=ms3000000366766127, createdTime=Wed Sep 29 15:07:44 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056125, encodeId=f204105612542, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24d05619594, createdName=ms3000000366766127, createdTime=Wed Sep 29 15:07:10 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013550, encodeId=1a051013550cf, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee6d5591864, createdName=ms6000000226610455, createdTime=Wed Sep 01 20:49:40 CST 2021, time=2021-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009096, encodeId=511710090960c, content=点赞👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/88514d1d39d84f3ba85db20af43d358d/2ce7a3acea30442ab95b578d804b69bc.jpg, createdBy=a9525438381, createdName=于四方, createdTime=Wed Aug 18 14:54:54 CST 2021, time=2021-08-18, status=1, ipAttribution=)]
    2021-09-01 ms6000000226610455

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1190734, encodeId=ea0d1190e344a, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f922820053, createdName=pp.dog.1001, createdTime=Mon Feb 07 14:42:47 CST 2022, time=2022-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056126, encodeId=eec61056126ef, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24d05619594, createdName=ms3000000366766127, createdTime=Wed Sep 29 15:07:44 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056125, encodeId=f204105612542, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24d05619594, createdName=ms3000000366766127, createdTime=Wed Sep 29 15:07:10 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1013550, encodeId=1a051013550cf, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee6d5591864, createdName=ms6000000226610455, createdTime=Wed Sep 01 20:49:40 CST 2021, time=2021-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009096, encodeId=511710090960c, content=点赞👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/88514d1d39d84f3ba85db20af43d358d/2ce7a3acea30442ab95b578d804b69bc.jpg, createdBy=a9525438381, createdName=于四方, createdTime=Wed Aug 18 14:54:54 CST 2021, time=2021-08-18, status=1, ipAttribution=)]
    2021-08-18 于四方

    点赞👍

    0

相关指南

原发性免疫缺陷病抗感染治疗与预防专家共识

中华医学会儿科学分会免疫学组 · 2017-04-28

拓展阅读

原发性免疫缺陷病抗感染治疗与预防专家共识

中华医学会儿科学分会免疫学组 · 2017-04-28

Baidu
map
Baidu
map
Baidu
map